Wird geladen...
Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors
BACKGROUND. Small-molecule tyrosine kinase inhibitors (TKIs) may provide an effective therapeutic option in patients with hematologic malignancies and solid tumors. However, cardiovascular (CV) events, including hypertension, heart failure, left ventricular systolic dysfunction, and QT prolongation,...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AlphaMed Press
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755926/ https://ncbi.nlm.nih.gov/pubmed/23918069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0466 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|